Esperion Therapeutics Inc... (ESPR)
2.14
-0.10 (-4.46%)
At close: Jan 15, 2025, 12:43 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY02 | FY01 | FY00 | FY99 |
| PE Ratio | -1.47 | -1.44 | -0.45 | -4.3 | -14.82 | -6.1 | -9.44 | -3.76 | -9.85 | -18.2 | -8.06 | -11.86 | -12.88 | -2.11 | -2.27 | -1.55 | -1.83 |
| PS Ratio | 2.65 | 5.48 | 1.84 | 3.14 | 10.89 | 6.67 | n/a | n/a | n/a | n/a | 0.04 | n/a | n/a | n/a | n/a | 21.38K | n/a |
| PB Ratio | -0.68 | -0.31 | -0.13 | -0.85 | -2.32 | -2.06 | 6.44 | 1.23 | 1.71 | 4.96 | 2.84 | -8.01 | -23 | 1.57 | 0.85 | 0.63 | 6.93 |
| P/FCF Ratio | -2.28 | -2.37 | -0.55 | -7.25 | -22.66 | -8.27 | -12 | -5.9 | -12.74 | -20.13 | -11.58 | -12.88 | -15.3 | -2.19 | -2.29 | -2.22 | -2.07 |
| P/OCF Ratio | -2.28 | -2.37 | -0.55 | -8.39 | -22.97 | -8.28 | -12 | -5.91 | -12.85 | -20.68 | -11.6 | -12.89 | -15.36 | -2.29 | -2.49 | -2.38 | -2.48 |
| OCF/S Ratio | -1.16 | -2.32 | -3.36 | -0.37 | -0.47 | -0.81 | n/a | n/a | n/a | n/a | -0.00 | n/a | n/a | n/a | n/a | -8.98K | n/a |
| Debt / Equity Ratio | -1.19 | -0.19 | -0.24 | -0.22 | -0.00 | n/a | 0.00 | 0.01 | 0.01 | 0.04 | n/a | -1.31 | -1.14 | 0.23 | 0.10 | 0.06 | 0.99 |
| Quick Ratio | 0.87 | 2.29 | 4.02 | 3.51 | 3.20 | 2.22 | 6.15 | 13.70 | 38.11 | 19.44 | 14.42 | 0.42 | 1.39 | 9.18 | 11.21 | 9.97 | 2.08 |
| Current Ratio | 1.29 | 2.67 | 4.48 | 3.68 | 3.20 | 2.22 | 6.15 | 13.70 | 38.11 | 19.44 | 14.42 | 0.42 | 1.39 | 9.18 | 11.21 | 9.97 | 2.08 |
| Asset Turnover | 0.57 | 0.30 | 0.21 | 0.64 | 0.69 | 1.29 | n/a | n/a | n/a | n/a | 63.57 | n/a | n/a | n/a | n/a | 0.00 | n/a |
| Interest Coverage | -2.64 | -3.16 | -4.89 | -5.35 | -11.47 | -2.05K | -853.44 | -202.53 | -96.23 | -134.16 | -24.3 | -6.86 | -17.61 | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | 0.46 | 0.21 | 0.29 | 0.20 | 0.16 | 0.34 | -0.68 | -0.33 | -0.17 | -0.27 | -0.35 | 0.68 | 1.79 | -0.74 | -0.37 | -0.41 | -3.79 |
| Return on Assets (ROA) | -1.02 | -1.16 | -0.84 | -0.47 | -0.51 | -1.41 | -0.6 | -0.31 | -0.17 | -0.25 | -0.33 | -1.61 | -4.96 | -0.56 | -0.32 | -0.35 | -1.33 |
| Return on Capital (ROIC) | -3.14 | -1.15 | -0.74 | -0.47 | -0.63 | -2.59 | -0.69 | -0.33 | -0.17 | -0.26 | -0.31 | 1.03 | -12.09 | -0.6 | -0.38 | -0.39 | -2.43 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 62.81% | 64.27% | 81.88% | 98.95% | -18.36% | 99.86% | n/a | n/a | n/a | n/a | 100.00% | n/a | n/a | n/a | n/a | -39.20K% | n/a |
| Net Profit Margin | -179.87% | -381.34% | -406.42% | -73.04% | -73.48% | -109.4% | n/a | n/a | n/a | n/a | -0.52% | n/a | n/a | n/a | n/a | -1.38M% | n/a |
| Pretax Profit Margin | -179.87% | -309.58% | -343.04% | -63.09% | -65.49% | -109.4% | n/a | n/a | n/a | n/a | -0.52% | n/a | n/a | n/a | n/a | -1.57M% | n/a |
| Operating Profit Margin | -133.72% | -237.83% | -289.02% | -53.35% | -62.75% | -110.9% | n/a | n/a | n/a | n/a | -0.46% | n/a | n/a | n/a | n/a | -1.38M% | n/a |
| FCF Margin | -116.46% | -231.64% | -336.29% | -43.31% | -48.05% | -80.66% | n/a | n/a | n/a | n/a | -0.36% | n/a | n/a | n/a | n/a | -964.75K% | n/a |
| EBITDA Margin | -129.03% | -233.65% | -283.18% | -52.88% | -59.8% | -110.76% | n/a | n/a | n/a | n/a | -0.46% | n/a | n/a | n/a | n/a | -1.28M% | n/a |